Free Trial
NASDAQ:CDTTW

Conduit Pharmaceuticals (CDTTW) Stock Price, News & Analysis

$0.02
+0.01 (+71.43%)
(As of 06/11/2024 ET)
Today's Range
$0.02
$0.03
50-Day Range
$0.02
$0.10
52-Week Range
$0.01
$0.18
Volume
2,545 shs
Average Volume
13,202 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

CDTTW Stock Price History

CDTTW Stock News Headlines

Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today?
See More Headlines
Receive CDTTW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Conduit Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CDTTW
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. David Joszef Tapolczay (Age 65)
    CEO & Director
    Comp: $419.8k
  • Mr. Adam Sragovicz (Age 54)
    Chief Financial Officer
    Comp: $116.67k
  • Dr. Joanne M. Holland (Age 49)
    Chief Scientific Officer

CDTTW Stock Analysis - Frequently Asked Questions

How have CDTTW shares performed in 2024?

Conduit Pharmaceuticals' stock was trading at $0.0693 at the start of the year. Since then, CDTTW shares have decreased by 65.4% and is now trading at $0.0240.
View the best growth stocks for 2024 here
.

How do I buy shares of Conduit Pharmaceuticals?

Shares of CDTTW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CDTTW) was last updated on 6/11/2024 by MarketBeat.com Staff

From Our Partners